TLM reduced TGF-β levels in NSCLC lung tumors, which was linked to PPAR-γ activation, VEGF, and MMP-9 inhibition, resulting in more nanoparticle penetration into the tumor [28,31,32]. The gene discussed is MMP9; the disease is neoplasm.